Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

icate superior protection when compared to similar viral challenge studies for competitive vaccine designs currently in human clinical trials. We are therefore very excited about the potential for our vaccine."

Dr. McNally continued, "On the financial side, we continue to benefit from NIH/HVTN support of our human clinical trials and we are seeking additional government support to fund our internal research and development activities to expand the use of our technology against strains (clades) of the HIV virus affecting other areas of the globe. From December 2011 to March 2012, we raised a total of $2.7 million in equity capital to bolster our cash reserves."

Comment on Gilead Science's Truvada® Prevention SubmissionDr. McNally also commented on the recent news related to an advisory panel's recommendation that the FDA approve Gilead Science's submission of their anti-viral medication, Truvada, for prevention of HIV. "While any positive step towards the control of this deadly disease is greatly welcomed, we must continue the search for safe, cost-effective measures to prevent HIV transmission. The high cost of oral medications, patient compliance, and risk of medical side effects clearly suggest the best solution still lies with a preventive vaccine. GeoVax's preventive vaccine is considered a leading candidate for the version of the virus prevalent in North and South America, and Europe."

Financial ReviewGeoVax reported a net loss for the three months ended March 31, 2012 of $730,513, or $0.04 per share, based on 16.7 million weighted average shares outstanding. For the three months ended March 31, 2011, the Company reported a loss of $606,282, or $0.04 per share, based on 15.7 million weighted average shares outstanding.

The Company reported revenues of $854,063 for the three months ended March 31, 2012, related to its Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institutes
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... and six months ended June 30, 2015. ... are progressing and we continue to expect results in ... president and chief executive officer of Rigel. "We are ... programs, including evaluating fostamatinib for new treatment indications, as ...
(Date:8/4/2015)... FRAMINGHAM, Mass. , Aug. 4, 2015 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that its President and Chief Executive ... at the Canaccord Genuity 35th Annual Growth Conference at ... conference is being held August 12-13, 2015 at the ...
(Date:8/4/2015)... , Aug. 4, 2015 Levi & ... Inc. ("Biogen" or the "Company") (NASDAQGS: BIIB) for possible ... Biogen and certain of its officers and/or directors have ... Act of 1934.  On Friday, July 24, 2015, prior ... second quarter 2015 financial results. Among other things, the ...
Breaking Medicine Technology:Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2
... Orthopedics This Week, the most widely read publication ... the winners of its 2010 Best Spine Technologies of ... and engineers for extraordinary innovation, hard work and effectiveness ... Winners were recognized at a gala awards ...
... each year on medical devices and equipment that are ... if purchased in the open-market according to a recent ... The study empirically shows that GPOs fail to deliver ... kickbacks from suppliers, and that they do not in ...
Cached Medicine Technology:Orthopedics This Week Announces 2010 Best Spine Technology Award Winners 2GPOs Fail to Provide Hospitals and Patients Health Care Savings 2
(Date:8/5/2015)... ... August 05, 2015 , ... " Wildflower Seed & Tool Company ... a look small, medium, and large businesses making an impact in their industry. Susan ... shared with viewers how their gardening tools are specifically designed for women. , With ...
(Date:8/5/2015)... ... August 05, 2015 , ... Available in select spas and at ... quartet of beauty-enhancing marine and plant oils. A perfect complement to Phytomer’s top selling ... out for its lovely scent and soothing properties. Formulated as a light and comfortable ...
(Date:8/5/2015)... ... August 05, 2015 , ... As the nation’s premier ... education and support in order to reduce the incidence of brain aneurysms and ... year it has awarded the most funding in the 20-year history of the ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... global clinical data standards. Members of global organisations such as PhUSE or CDISC ... such as the American FDA, the Japanese PMDA and the European EMA. A ...
(Date:8/4/2015)... ... August 05, 2015 , ... ... corporation, Crestwood Midstream, to store liquid propane gas (LPG) next to Seneca Lake*, ... workers union, unanimously passed a resolution that strongly opposes that permit. *, ** ...
Breaking Medicine News(10 mins):Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3
... containing benadryl linked to slowed thinking, delirium in ... News) --Older people taking common over-the-counter drugs for ... increase their risk for cognitive impairment, including delirium, ... include Benadryl, Dramamine, Excedrin PM, Nytol, Sominex, Tylenol ...
... healthcare IT company by revenue , , HATBORO, Pa., June ... IFLG ), a leading technology provider of enterprise mobility solutions for ... been named to Healthcare Informatics , ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Programs Give Seniors Helpful Solutions , , HOUSTON, ... nation,s largest non-profit organization for seniors, with over 500,000 ... Support & Financial and Retirement Planning. , , ... of resources to SCB members, with the goal of ...
... ... based clinic - The London Clinic. The contract marks the world,s first live site of ... ... leading provider of clinical workflow and integration technology for the health care sector world-wide, has ...
... Best ... minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud to announce ... ,The site is unique in its offering of popularly prescribed "discreet" prescription drugs ...
... PROVO, Utah, June 4 Nu Skin Enterprises, Inc. (NYSE: ... has declared a quarterly dividend of $0.115 per share, which ... record on June 15, 2009. , , The ... has been demonstrating its tradition of innovation through its comprehensive ...
Cached Medicine News:Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 2Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 3Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 3Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2
50L...
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
250L...
Medicine Products: